NCT01914939View on ClinicalTrials.gov

A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Autism Spectrum Disorders
Interventions
DRUG

Oxytocin

BEHAVIORAL

Social Skills focused CBT

BEHAVIORAL

Stress management/relaxation training

DRUG

placebo drug

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02139

Massachusetts Institute of Technology Martinos Imaging Center, Cambridge

All Listed Sponsors
collaborator

Massachusetts Institute of Technology

OTHER

lead

Massachusetts General Hospital

OTHER

NCT01914939 - A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder | Biotech Hunter | Biotech Hunter